Related Experiment Video
Updated: Apr 9, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Failed transition to buprenorphine extended-release injection from high-dose methadone
Archana Jhawar1, Shannon Menard-Okoroike2
1(Corresponding author) Clinical Pharmacy Practitioner-Psychiatry, Jesse Brown Veterans Administration Medical Center, Chicago, Illinois; Clinical Assistant Professor, University of Illinois Chicago, Retzky College of Pharmacy, Chicago, Illinois, archanaj@uic.edu.
Transitioning patients from full agonist opioids to buprenorphine can be challenging. High-dose opioid use, rapid transitions, and patient reluctance are risk factors for buprenorphine induction failure.
Area of Science:
- Addiction Medicine
- Pharmacology
Background:
- Opioid withdrawal during buprenorphine induction presents significant challenges for patients on full agonist opioids.
- While many strategies exist for successful induction, risk factors for transition failure remain under-researched.
Related Concept Videos
Oral Drug Delivery Systems: Continuous-Release Systems
IV Infusion to Oral Dosing: Conversion Methods
Modified-Release Drug Delivery Systems: Overview
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Desensitization and Tachyphylaxis

